Literature DB >> 17967825

Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test.

Norihiro Morikawa1, Yasuyuki Kawai, Kenichiro Arakawa, Teruhiko Kumamoto, Isamu Miyamori, Hironobu Akao, Michihiko Kitayama, Kouji Kajinami, Jong-Dae Lee, Haruo Takeshita, Yoshihiko Kominato, Toshihiro Yasuda.   

Abstract

AIMS: Serum deoxyribonuclease I (DNase I) activity has recently been highlighted as a potential diagnostic marker for detection of acute myocardial infarction. To evaluate whether serum DNase I activity is useful for detection of myocardial ischaemia, we investigated alteration of its levels after onset of vasospastic angina pectoris (VSAP), resulting in transient myocardial ischaemia, induced by the intracoronary ergonovine provocation test. METHODS AND
RESULTS: Twenty-nine consecutive patients with suspected VSAP were subjected to the test. Patients were categorized as VSAP-positive (n = 13) or -negative (n = 16) based on development of angina. Serum samples were examined for DNase I activity before, immediately after, and 3, 6, and 24 h after the provocation tests. The serum DNase I activity increased significantly from the baseline 3 h after the provocation test in 11 patients of the VSAP-positive group whose levels of troponin T were within the normal range. Median of the percentage differences from the baseline in serum DNase I activity 3 h after the test was 32.1% (25th and 75th percentile: 28.6 and 42.0%, respectively; P = 0.000012). In the VSAP-negative group, levels of DNase I activity remained unchanged at any point of time after the provocation test.
CONCLUSION: Transient myocardial ischaemia resulting from VSAP induces a significant elevation of serum DNase I activity. Therefore, serum DNase I activity may be applicable as a useful marker for detecting transient myocardial ischaemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967825     DOI: 10.1093/eurheartj/ehm483

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction.

Authors:  Kristina Gopcevic; Branislav Rovcanin; Dusan Kekic; Sandra Radenkovic
Journal:  Mol Cell Biochem       Date:  2010-12-28       Impact factor: 3.396

2.  VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice.

Authors:  Alexander S Savchenko; Julian I Borissoff; Kimberly Martinod; Simon F De Meyer; Maureen Gallant; Luise Erpenbeck; Alexander Brill; Yanming Wang; Denisa D Wagner
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

3.  Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state.

Authors:  Julian I Borissoff; Ivo A Joosen; Mathijs O Versteylen; Alexander Brill; Tobias A Fuchs; Alexander S Savchenko; Maureen Gallant; Kimberly Martinod; Hugo Ten Cate; Leonard Hofstra; Harry J Crijns; Denisa D Wagner; Bas L J H Kietselaer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-01       Impact factor: 8.311

Review 4.  Deoxyribonucleases and Their Applications in Biomedicine.

Authors:  Lucia Lauková; Barbora Konečná; Ľubica Janovičová; Barbora Vlková; Peter Celec
Journal:  Biomolecules       Date:  2020-07-11

5.  Expanding the Toolbox for Label-Free Enzyme Assays: A Dinuclear Platinum(II) Complex/DNA Ensemble with Switchable Near-IR Emission.

Authors:  Moustafa T Gabr; F Christopher Pigge
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

Review 6.  Highly sensitive nuclease assays based on chemically modified DNA or RNA.

Authors:  Shinobu Sato; Shigeori Takenaka
Journal:  Sensors (Basel)       Date:  2014-07-11       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.